Market Value5,935,681,007
Total Holdings63
File Date2025-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SRRK / Scholar Rock Holding Corporation
AVTX / Avalo Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
ALEC / Alector, Inc.
ACHC / Acadia Healthcare Company, Inc.
PCSC / Perceptive Capital Solutions Corp
WVE / Wave Life Sciences Ltd.
APGE / Apogee Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
SCILEX HOLDING CO / SH (80880W106)
NRIX / Nurix Therapeutics, Inc.
IMTX / Immatics N.V.
ASND / Ascendis Pharma A/S
URGN / UroGen Pharma Ltd.
IFRX / InflaRx N.V.
GKOS / Glaukos Corporation
MTSR / Metsera, Inc.
AVTE / Aerovate Therapeutics, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
ACET / Adicet Bio, Inc.
TARA / Protara Therapeutics, Inc.
ELVN / Enliven Therapeutics, Inc.
TRML / Tourmaline Bio, Inc.
ACLX / Arcellx, Inc.
RCUS / Arcus Biosciences, Inc.
CDTX / Cidara Therapeutics, Inc.
BOLD / Boundless Bio, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
FDMT / 4D Molecular Therapeutics, Inc.
GHRS / GH Research PLC
TSHA / Taysha Gene Therapies, Inc.
PEPG / PepGen Inc.
ARTV / Artiva Biotherapeutics, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
TVTX / Travere Therapeutics, Inc.
MNPR / Monopar Therapeutics Inc.
NAMS / NewAmsterdam Pharma Company N.V.
SPRY / ARS Pharmaceuticals, Inc.
DRUG / Bright Minds Biosciences Inc.
BCAX / Bicara Therapeutics Inc.
BIOA / BioAge Labs, Inc.
XNCR / Xencor, Inc.
VOR / Vor Biopharma Inc.
ELYM / Eliem Therapeutics, Inc.
SEPN / Septerna, Inc.
EWTX / Edgewise Therapeutics, Inc.
STRO / Sutro Biopharma, Inc.
ETNB / 89bio, Inc.
TNGX / Tango Therapeutics, Inc.
NAMS.W / NewAmsterdam Pharma Company N.V. - Equity Warrant
CBLL / CeriBell, Inc.
HUMA / Humacyte, Inc.
CTMX / CytomX Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
KURA / Kura Oncology, Inc.
HOWL / Werewolf Therapeutics, Inc.
SRZN / Surrozen, Inc.
EYPT / EyePoint, Inc.
ATXS / Astria Therapeutics, Inc.
RXST / RxSight, Inc.
LRMR / Larimar Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
SION / Sionna Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
DNTH / Dianthus Therapeutics, Inc.
BBNX / Beta Bionics, Inc.
ACRS / Aclaris Therapeutics, Inc.
SERA / Sera Prognostics, Inc.
MBX / MBX Biosciences, Inc.
OMDA / Omada Health, Inc.
LENZ / LENZ Therapeutics, Inc.
TXG / 10x Genomics, Inc.
HNGE / Hinge Health, Inc.
WGS / GeneDx Holdings Corp.
IRON / Disc Medicine, Inc.
JBIO / Jade Biosciences, Inc.
ELDN / Eledon Pharmaceuticals, Inc.
JANX / Janux Therapeutics, Inc.
LXEO / Lexeo Therapeutics, Inc.
ZURA / Zura Bio Limited
RNA / Atrium Therapeutics, Inc.
TYRA / Tyra Biosciences, Inc.
ACRV / Acrivon Therapeutics, Inc.
NKTX / Nkarta, Inc.
GERN / Geron Corporation
SLDB / Solid Biosciences Inc.
MLYS / Mineralys Therapeutics, Inc.